ARCHIVES

FDA Plans to Discuss the Negative Trial of AstraZeneca’s Drug Iressa With the Oncologic Drugs Advisory Committee in March.

This article is from The Cancer Letter archive.

Vol. 31 No. 03 | January 21, 2005

Download PDF Visit The Full Archive

Related Articles

ORI Says COMS Study Coordinator Committed Scientific Misconduct

April 12, 1996

Funding Opportunities: Aging Institute Offers Program Announcement

February 6, 1998

Tests Find No Conclusive Evidence On Two Chemicals

September 21, 1979

Oxford Univ. Receives Funds To Create Drug Design Center.

October 6, 2000

Funding Opportunities

October 25, 2002

DCC Board Approves Concept for Computer System To Reduce Dependence On NIH

June 1, 1990